Christopher J. P. Velis
Gründer bei Audax Medical, Inc.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Mark A. Johanson | M | - |
Audax Medical, Inc.
 Audax Medical, Inc. Medical SpecialtiesHealth Technology Audax Medical, Inc. operates as an orthopedic company that focuses on the development of a regenerative biomaterial. It develops Arxis, a self-assembling bioresorbable nanocomposite that can be used in minimally-invasive orthopedic reconstructive surgery. The company was founded by Mark A. Johanson, Christopher J. P. Velis in 2009 and is headquartered in Concord, MA. | 15 Jahre |
| Donald Ingber | M | - |
BOA Biomedical, Inc.
 BOA Biomedical, Inc. Medical SpecialtiesHealth Technology BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis. | - |
| Jason King | M | - |
Miraki Innovation, Inc.
 Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | 5 Jahre |
| Robert J. Depasqua | M | - |
Audax Medical, Inc.
Audax Medical, Inc. Medical SpecialtiesHealth Technology Audax Medical, Inc. operates as an orthopedic company that focuses on the development of a regenerative biomaterial. It develops Arxis, a self-assembling bioresorbable nanocomposite that can be used in minimally-invasive orthopedic reconstructive surgery. The company was founded by Mark A. Johanson, Christopher J. P. Velis in 2009 and is headquartered in Concord, MA. | - |
| Joseph Cari | M | - |
Medcap Growth Equity GP LP
 Medcap Growth Equity GP LP Investment Trusts/Mutual FundsMiscellaneous MedCap Growth Equity GP LP operates as a venture capital fund. The company is headquartered in Cambridge, MA. | - |
| Floyd Samuel Eberts | M | - |
Medcap Growth Equity GP LP
Medcap Growth Equity GP LP Investment Trusts/Mutual FundsMiscellaneous MedCap Growth Equity GP LP operates as a venture capital fund. The company is headquartered in Cambridge, MA. | - |
| Nisha Varma | F | - |
BOA Biomedical, Inc.
BOA Biomedical, Inc. Medical SpecialtiesHealth Technology BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis. | - |
| Earl Kishida | M | - |
BOA Biomedical, Inc.
BOA Biomedical, Inc. Medical SpecialtiesHealth Technology BOA Biomedical, Inc. is a Miraki innovation company that focuses on infectious disease. The private company is based in Cambridge, MA. The company's mission is to provide innovative tools to fight the world's most deadly infectious diseases and their outcomes, including sepsis, hospital-acquired infections, antibiotic resistance, pandemic infections, pathogenic outbreaks, and the threat of bioterrorism. BOA Biomedical has an exclusive license to technology from the Wyss Institute. The company's platform manages infectious disease throughout the patient journey from diagnosis to tracking to treatment. The company was founded by Christopher J. P. Velis. | - |
| Susan Arias | F | - |
Miraki Innovation, Inc.
Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | 6 Jahre |
| Natalia Trujillo | F | - |
Miraki Innovation, Inc.
Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | 9 Jahre |
| Tom Duquette | M | - |
Miraki Innovation, Inc.
Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | 5 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| John Allspaw | M | 53 |
University of Massachusetts Amherst
| 7 Jahre |
| Kumar Ganapathy | M | - |
University of Massachusetts Amherst
| 2 Jahre |
| Jon Roskill | M | - |
University of Massachusetts Amherst
| 5 Jahre |
| Gabe Fenton | M | - |
University of Massachusetts Amherst
| 3 Jahre |
| Paula Drake | F | - |
University of Massachusetts Amherst
| 10 Jahre |
| Iris Krug | F | - |
University of Massachusetts Amherst
| 4 Jahre |
| Qiang Sun | M | - |
University of Massachusetts Amherst
| 3 Jahre |
| DONAHUE KEVIN J. | M | - |
University of Massachusetts Amherst
| 4 Jahre |
| Julie Kittler | F | - |
University of Massachusetts Amherst
| 4 Jahre |
| Terry Rauch | M | - |
Miraki Innovation, Inc.
Miraki Innovation, Inc. Investment ManagersFinance Miraki Innovation, Inc. is an Independent Private Equity/Venture Capital firm founded in 2019 by Christopher J. P. Velis. Miraki Innovation, Inc. is headquartered in Cambridge, Massachusetts. | 3 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 21 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Christopher J. P. Velis
- Persönliches Netzwerk
